iomeprol
Sign in to saveAlso known as N,N'-Bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(N-methylglycolamido)isophthalamide
Iomeprol, sold under the brand name Imeron among others, is a medication used as a radiocontrast agent in X-ray imaging.
Research
948 papers- Iomeprol: a review of its use as a contrast medium.Drugs · 2000
- Clinical pharmacology of iomeprol.European journal of radiology · 1994
- Iomeprol-induced acute generalised exanthematous pustulosis (AGEP).BMJ case reports · 2025
- Clinical utility and safety profile of iomeprol.European journal of radiology · 1994
- Stability testing of iomeprol and iopamidol formulations subjected to X-ray radiation.Radiography (London, England : 1995) · 2024
via PubMed
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 776.854
Show 4 more facts
- chemical formula
- C₁₇H₂₂I₃N₃O₈
- canonical SMILES
- CN(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO
- World Health Organisation international non-proprietary name
- iomeprol
- subject has role
- contrast agent
Sources (2)
via Wikidata · CC0
~1 min read
Encyclopedic overview
5 sectionsContents
- Side effects
- Society and culture
- Legal status
- Brand names
- References
Iomeprol, sold under the brand name Imeron among others, is a medication used as a radiocontrast agent in X-ray imaging.
Iomeprol was approved for medical use in the United States in November 2024.
Excerpted from Wikipedia’s “iomeprol” article, available under the CC BY-SA 4.0 licence.
Available in 7 languages
via Wikidata sitelinks · CC0